Our siRNA Design Services help research teams move from a gene or transcript target to a prioritized set of small interfering RNA candidates with clearer design rationale and lower avoidable sequence risk. Effective siRNA design depends on more than selecting a short complementary sequence. Transcript choice, isoform coverage, local target accessibility, guide-strand loading, seed-region behavior, sequence complexity, off-target similarity, polymorphisms, and compatibility with planned chemical modifications can all influence experimental performance.
We combine sequence analysis with practical RNAi development considerations and can connect design projects with siRNA synthesis, RNAi workflow support, and RNA delivery development when clients need an integrated path from in silico prioritization to research testing. Deliverables are designed to support transparent candidate selection rather than present a single sequence as universally optimal.
Wrong Transcript Target: Genes may have multiple transcript isoforms, alternative exons, paralogs, or closely related family members. A sequence chosen against the wrong transcript region can miss the intended isoform or create unwanted cross-reactivity.
Seed-Mediated Off-Targets: Partial complementarity, particularly involving the guide-strand seed region, can contribute to unintended transcript effects even when no near-perfect full-length match is present. Candidate review therefore considers more than simple whole-sequence identity.
Poor Strand Bias: Duplex-end stability and nucleotide context can influence which strand is preferentially loaded into the RNA-induced silencing complex. Designs should favor the intended guide while reducing the chance that the passenger strand contributes unwanted activity.
Inaccessible Target Regions: Local mRNA structure, protein occupancy, and transcript context can make some complementary sites less accessible than others. Computational accessibility metrics are useful for ranking but should be paired with experimental validation.
Modification Conflicts: Chemical stabilization, conjugation, and delivery requirements may change how a sequence behaves. A design that looks acceptable as an unmodified duplex can require adjustment once modification patterns or terminal conjugates are introduced.
Single-Candidate Risk: siRNA activity remains partly empirical. Designing a small, well-differentiated candidate panel gives research teams a stronger basis for screening, confirmation, and independent-sequence validation.
Projects can start from a gene symbol, transcript accession, client-provided sequence, or an existing siRNA that needs redesign. We document the design assumptions used to rank candidates and can tailor the analysis to isoform specificity, broad transcript coverage, or difficult target regions.
For teams that already have validated sequences, predesigned siRNA or custom synthesis may be more appropriate. For discovery programs, our design workflow emphasizes candidate diversity, off-target review, and compatibility with downstream siRNA conjugation or labeling plans.
No single rule predicts performance perfectly. Candidate ranking is strongest when sequence, specificity, strand bias, accessibility, and downstream chemistry are considered together.
| Design Factor | Why It Matters | What We Assess | Common Warning Sign | Design Response |
| Target transcript | Defines what sequence is actually being silenced | Accession, isoforms, exon coverage, gene family | Ambiguous or outdated reference sequence | Confirm reference and intended isoform coverage |
| Seed region | Can contribute to miRNA-like off-target interactions | Seed composition and transcriptome similarity | High-risk partial matches in unrelated transcripts | Re-rank or redesign candidate |
| Duplex asymmetry | Influences guide/passenger strand preference | Relative end stability and 5′ nucleotide context | Passenger strand favored by duplex-end features | Adjust target site or strand design |
| GC balance | Affects duplex stability and sequence behavior | Overall composition and local GC runs | Extreme GC content or long GC stretches | Select alternate target window |
| Target accessibility | May affect RISC access to the mRNA | Predicted local structure and sequence context | Highly structured candidate region | Include alternative accessible sites |
| Sequence uniqueness | Reduces direct cross-reactivity | Near-match and gene-family homology review | High similarity to paralogs or repeated regions | Exclude or use isoform-specific design logic |
| Modification compatibility | Connects design to synthesis and delivery | Planned 2′ modifications, terminal groups, conjugates | Critical positions overloaded with modifications | Revise modification map or candidate |
The design package can be scaled from a focused candidate set to a broader screening panel depending on how much biological validation is planned.
| Project Need | Recommended Output | Key Analysis | Best Fit | Next Step |
| Single-gene feasibility | Small ranked candidate set | Transcript confirmation, sequence filters, off-target review | Early target validation | Order individual duplexes and screen |
| Isoform-specific knockdown | Candidates in unique transcript regions | Exon mapping, isoform comparison, specificity review | Transcript-discrimination studies | Confirm expression of target isoform before testing |
| Gene-family selectivity | Candidates minimizing paralog similarity | Family alignment and near-match analysis | Closely related gene targets | Test multiple independent sequences |
| Screening panel | Larger candidate list or plate-ready design set | Automated filters plus diversity review | Medium-throughput RNAi experiments | Synthesis, pooling, and plate formatting |
| Modified siRNA program | Design plus modification map | Sequence/function constraints and chemistry compatibility | Stability or delivery-oriented studies | Synthesis and analytical confirmation |
| Conjugated siRNA program | Candidate plus terminal/conjugation design | Attachment site, linker, modification compatibility | Ligand or carrier evaluation | Conjugation and delivery testing |
The workflow makes the transcript reference and design assumptions explicit before candidate ranking, which helps prevent downstream confusion when gene models or project goals change.
We confirm the gene, species, transcript accession, isoform objective, and experiment type. Existing sequences, known problem regions, and required modifications are captured at the start.
The reference transcript is reviewed for exon structure, shared or unique regions, sequence ambiguity, and homology to related genes. This defines which target windows should be included or excluded.
Multiple siRNA target sites are generated and filtered using sequence-composition, duplex, motif, and strand-selection criteria. Candidate diversity is maintained to reduce dependence on a single prediction rule.
Candidates are compared against relevant sequence data to identify near-matches, seed-related concerns, and gene-family cross-reactivity. High-risk sequences are removed or deprioritized.
Specificity, asymmetry, accessibility, modification needs, and synthesis practicality are combined into a documented ranking. Where tradeoffs exist, we show the reason rather than hiding them behind a single score.
The final package includes selected candidates, sequence annotations, design notes, and recommended controls. Projects can proceed into synthesis, labeling, conjugation, or RNAi testing as required.
A transparent, multi-parameter design process helps research teams understand why candidates were selected and where experimental uncertainty remains.
Custom siRNA design supports research programs that require sequence-specific gene suppression and clear control over target definition.
If you have a gene, transcript accession, existing siRNA, or difficult target region, we can build a design package that combines transcript review, specificity analysis, strand-selection logic, and downstream chemistry considerations. Contact us to discuss your project requirements.
A gene or transcript identifier, species, intended isoform coverage, and any sequence or modification constraints are the most useful starting inputs.
A small panel of independent candidates is generally more informative than relying on one predicted sequence. The appropriate number depends on target complexity and the planned screening workflow.
Candidate sequences are reviewed for near-matches, gene-family similarity, and seed-region complementarity that may contribute to unintended transcript effects.
Differences in duplex-end stability and nucleotide context can influence which strand is preferentially loaded into the RNA-induced silencing complex. Design can favor the intended guide strand.
Yes, when the target isoform contains sufficiently unique sequence regions. Exon structure and sequence similarity to other isoforms are reviewed before candidate selection.
Loading ......
